[Photo] An Jae-yong, SK Bioscience President, Receiving Skycovione Vaccination View original image

[Asia Economy Reporter Lee Chun-hee] On the 19th, Ahn Jae-yong, CEO of SK Bioscience, received the fourth dose of the COVID-19 vaccine 'Skycovione,' a domestically developed COVID-19 vaccine by SK Bioscience, at Hansarang Kim Kyung-hee Pediatric and Adolescent Clinic located in Seongnam-si, Gyeonggi Province.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing